Productivity Metric Considerations in MSC & MSC-EV Manufacturing in Response to COVID-19 May 15, 2020 Biomanufacturing, COVID-19, EVs & Exosomes
Accelerating COVID-19 Treatments with Patient Safety As First Priority April 29, 2020 Cell Therapy, COVID-19
The Race to Beat COVID-19 with hMSCs Revs Up April 24, 2020 Cell Therapy, COVID-19, MSCs & Characterization
Patience for hMSCs in COVID-19: We Must Crawl Before We Run April 14, 2020 BioEconomy, Cell Therapy, COVID-19, MSCs & Characterization
hMSCs: A Secret(ome) Weapon Against ARDS April 03, 2020 Cell Therapy, COVID-19, EVs & Exosomes, MSCs & Characterization
Can MSCs Treat Patients with COVID-19? March 18, 2020 Cell Therapy, COVID-19, MSCs & Characterization
Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19 March 13, 2020 Biomanufacturing, Cell Therapy, Corporate, COVID-19
WHITE PAPER: The Stabilization of hMSCs as a Technology March 05, 2020 BioEconomy, Biomanufacturing, Cell Therapy, Corporate
